<DOC>
	<DOCNO>NCT00428428</DOCNO>
	<brief_summary>The purpose study examine effect endoluminally administrate isoproterenol pelvic pressure increase flexible ureterorenoscopy 14 human . We propose isoproterenol potential reduce intrarenal pressure ureterorenoscopies . Lower intrarenal pressure may advantage facilitating procedure reduce intraoperative complication bleed infection .</brief_summary>
	<brief_title>Pharmacological Modulation Intrarenal Pressure During Endourological Procedures Upper Urinary Tract</brief_title>
	<detailed_description />
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Hematuria</mesh_term>
	<mesh_term>Isoproterenol</mesh_term>
	<criteria>Indication ureterorenoscopy Age &gt; 18 year Normal blood pressure Malignant disease upper urinary tract Heart disease Allergy Isoproterenol Use αblocking βblocking medicine Use Calciumantagonists Use NSAIDs last 48 hour Present stone JJstent ureter Neurologic disease bladder Pregnancy Nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>kidney stone</keyword>
	<keyword>ureteroscopy</keyword>
</DOC>